Stefano Settimi
Roma, Italy
NCT Number: NCT05746780
The aim of this study is to evaluate the role of elective bilateral neck dissection in patients with clinically negative lymph nodes (cN0) who underwent salvage total laryngectomy, by estimating the prevalence of histologically positive occult lymph nodes (pN+). Secondary objective will be the assessment of complication rate and the evaluation of 5-year Overall Survival (OS) and 5-year Disease-Specific Survival (DSS) in these patients.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Roma, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-patients affected by recurrent laryngeal cancer after primary treatment failure (surgery or radiotherapy or chemoradiotherapy), with no clinical or radiological evidence of lymph node metastasis in the neck (cN0),who underwent salvage total laryngectomy and concomitant bilateral elective neck dissection (levels II, III, IV and VI).
Exclusion criteria
Radical modified type 3 selective bilaterale elective neck dissection
Time frame: At the time of salvage surgery
Incidence rate of occult lymph node metastasislaryngectomy with clinically negative lymph nodes (cN0), estimating the prevalence of histologically positive lymph nodes (pN+) and predictive factors for cervical lymph nodes metastasis
Time frame: Up to 15 days from salvage surgery
Complications of bilateral neck dissection during hospitalization
Time frame: 5 year
Survival of the patient from any disease
Time frame: 5 years
Survival of the patient from laryngeal disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Clinical Value and Prognostic Impact of Bilateral Elective Neck Dissection in Salvage Total Laryngectomy of cN0 Cases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01194466
Head Cancer, Head and Neck Neoplasms
Iowa City, Iowa, United States
View Trial DetailsNCT06432998
Cancer Pain, Head and Neck Neoplasms
Santa Cruz de Tenerife, Tenerife, Spain
View Trial DetailsNCT04750434
Head Cancer, Head and Neck Neoplasms
Newport Beach, California, United States
View Trial DetailsNCT06010381
Arthralgia, Head and Neck Neoplasms
Cairo, Egypt
View Trial Details